X4 Pharmaceuticals, Inc. revenue for the last year amounted to 2.56 M USD, the most of which — 2.56 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 3.00 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought X4 Pharmaceuticals, Inc. 2.56 M USD, and the year before that — 3.00 M USD.